Opdivo Intravenous infusion 100mg, manufactured by Ono Pharmaceutical, contains Nivolumab (genetical recombination) and is an immune checkpoint inhibitor used to treat various cancers, including melanoma, lung cancer, and renal cell carcinoma. This 100mg 10mL bottle has a YJ code of 4291427A2020.
Opdivo Intravenous infusion 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →